Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Immunity
|
April 20, 2022
Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques
Ethan R Roy, Gabriel Chiu, Sanming Li, et al.
Neuron
|
November 13, 2018
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease
Alexandra Litvinchuk, Ying-Wooi Wan, Dan B Swartzlander, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 23, 2015
Human pluripotent stem cell-derived neural constructs for predicting neural toxicity
Michael P Schwartz, Zhonggang Hou, Nicholas E Propson, et al.
Nature Methods
|
April 12, 2011
Chemically defined conditions for human iPSC derivation and culture
Guokai Chen, Daniel R Gulbranson, Zhonggang Hou, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
June 11, 2017
Uniform neural tissue models produced on synthetic hydrogels using standard culture techniques
Christopher Barry, Matthew T Schmitz, Nicholas E Propson, et al.
The Journal of Clinical Investigation
|
January 10, 2020
Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease
Ethan R Roy, Baiping Wang, Ying-Wooi Wan, et al.
Cell Reports
|
August 23, 2025
Lysosomal polyamine storage upon ATP13A2 loss impairs β-glucocerebrosidase via altered lysosomal pH and electrostatic hydrolase-lipid interactions
Madhuja Samaddar, Gabriel A Fitzgerald, Ann Hong Nguyen, et al.
Molecular Neurodegeneration
|
August 7, 2025
LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome
Michael T Maloney, Xiang Wang, Rajarshi Ghosh, et al.
Science Translational Medicine
|
June 8, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease
Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
A Common PD-Risk <i>GBA1</i> Variant Disrupts LIMP2 Interaction, Impairs Glucocerebrosidase Function, and Drives Lysosomal and Mitochondrial Dysfunction
Oliver B Davis, Jennifer E Kung, Sonnet S Davis, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Immunity
|
April 20, 2022
Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques
Ethan R Roy, Gabriel Chiu, Sanming Li, et al.
Neuron
|
November 13, 2018
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease
Alexandra Litvinchuk, Ying-Wooi Wan, Dan B Swartzlander, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 23, 2015
Human pluripotent stem cell-derived neural constructs for predicting neural toxicity
Michael P Schwartz, Zhonggang Hou, Nicholas E Propson, et al.
Nature Methods
|
April 12, 2011
Chemically defined conditions for human iPSC derivation and culture
Guokai Chen, Daniel R Gulbranson, Zhonggang Hou, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
June 11, 2017
Uniform neural tissue models produced on synthetic hydrogels using standard culture techniques
Christopher Barry, Matthew T Schmitz, Nicholas E Propson, et al.
The Journal of Clinical Investigation
|
January 10, 2020
Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease
Ethan R Roy, Baiping Wang, Ying-Wooi Wan, et al.
Cell Reports
|
August 23, 2025
Lysosomal polyamine storage upon ATP13A2 loss impairs β-glucocerebrosidase via altered lysosomal pH and electrostatic hydrolase-lipid interactions
Madhuja Samaddar, Gabriel A Fitzgerald, Ann Hong Nguyen, et al.
Molecular Neurodegeneration
|
August 7, 2025
LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome
Michael T Maloney, Xiang Wang, Rajarshi Ghosh, et al.
Science Translational Medicine
|
June 8, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease
Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
A Common PD-Risk <i>GBA1</i> Variant Disrupts LIMP2 Interaction, Impairs Glucocerebrosidase Function, and Drives Lysosomal and Mitochondrial Dysfunction
Oliver B Davis, Jennifer E Kung, Sonnet S Davis, et al.
Page
of 3